Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer ; volume:14 ; number:1 ; day:13 ; month:9 ; year:2016 ; pages:1-9 ; date:12.2016
World journal of surgical oncology ; 14, Heft 1 (13.9.2016), 1-9, 12.2016
- Urheber
-
Park, Chansub
- Beteiligte Personen und Organisationen
-
Park, Kyeongmee
Kim, Jiyoung
Sin, Youngjoo
Park, Inseok
Cho, Hyunjin
Yang, Keunho
Bae, Byung Noe
Kim, Ki Whan
Ahn, Sookyung
Gwak, Geumhee
SpringerLink (Online service)
- DOI
-
10.1186/s12957-016-0999-x
- URN
-
urn:nbn:de:1111-20161014732
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Park, Chansub
- Park, Kyeongmee
- Kim, Jiyoung
- Sin, Youngjoo
- Park, Inseok
- Cho, Hyunjin
- Yang, Keunho
- Bae, Byung Noe
- Kim, Ki Whan
- Ahn, Sookyung
- Gwak, Geumhee
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer